Skip to main content

Table 2 Comparison of mean Serum creatinine between the 2 arms from baseline to day 28

From: Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Day

Mean SCr

Mean ± SD (mg/dl)

P-Value

Electrolyte Supplementation Arm (n)

Non-electrolyte Arm (n)

Day 0 (baseline)

0.9008 ± 0.1430 (49)

0.8948 ± 0.1960 (50)

0.8621

Day 7

0.9177 ± 0.1941 (47)

1.075 ± 0.3730 (44)

0.0126

Day 14

0.9902 ± 0.1876 (44)

1.264 ± 0.5493 (42)

0.0025

Day 21

0.8693 ± 0.2385 (42)

1.315 ± 0.6347 (41)

< 0.0001

Day 28

1.052 ± 0.3602 (26)

1.060 ± 0.2918 (25)

0.9305